CONTROLLED SUB-SCHED II Senate SponsorsSen. William E. Brady-Melinda Bush-Kyle McCarter 1/9/2019SenateSession Sine Die 720 ILCS 570/312from Ch. 56 1/2, par. 1312Amends the Illinois Controlled Substances Act. Provides that a registered pharmacist filling a prescription for an opioid substance listed in Schedule II may dispense the prescribed substance in a lesser quantity than the recommended full quantity indicated on the prescription if requested by the patient provided that the prescription complies with the requirements of the Act. Provides that the remaining quantity in excess of the quantity requested by the patient shall be void. Provides that if the dispensed quantity is less than the recommended full quantity, the pharmacist or his or her designee shall, within a reasonable time following a reduction in quantity but not more than 7 days, notify the prescribing practitioner of the quantity actually dispensed. Provides that nothing in this provision shall be interpreted to conflict with or supersede any other requirement established in the Act for a prescription of an opiate substance or any requirements or conditions for drug substitutions established in the Act. Effective immediately.Senate Committee Amendment No. 1 Provides that when issuing a prescription for an opiate to a patient 18 years of age or older for outpatient use for the first time, a practitioner may not issue a prescription for more than a 7-day supply. A practitioner may not issue an opiate prescription to a person under 18 years of age for more than a 7-day supply at any time and shall discuss with the parent or guardian of the person under 18 years of age the risks associated with opiate use and the reasons why the prescription is necessary. Provides that notwithstanding this provision, if, in the professional medical judgment of a practitioner, more than a 7-day supply of an opiate is required to treat the patient's acute medical condition or is necessary for the treatment of chronic pain management, pain associated with a cancer diagnoses, or for palliative care, then the practitioner may issue a prescription for the quantity needed to treat that acute medical condition, chronic pain, pain associated with a cancer diagnosis, or pain experienced while the patient is in palliative care. Provides that the condition triggering the prescription of an opiate for more than a 7-day supply shall be documented in the patient's medical record and the practitioner shall indicate that a non-opiate alternative was not appropriate to address the medical condition. Provides that these provisions do not apply to medications designed for the treatment of substance abuse or opioid dependence. 2/10/2017SenateFiled with Secretary by Sen. Tim Bivins 2/10/2017SenateFirst Reading 2/10/2017SenateReferred to Assignments 2/28/2017SenateAssigned to Licensed Activities and Pensions 3/6/2017SenateSenate Committee Amendment No. 1 Filed with Secretary by Sen. Tim Bivins 3/6/2017SenateSenate Committee Amendment No. 1 Referred to Assignments 3/8/2017SenateSenate Committee Amendment No. 1 Assignments Refers to Licensed Activities and Pensions 3/9/2017SenatePostponed - Licensed Activities and Pensions 3/9/2017SenateSenate Committee Amendment No. 1 Postponed - Licensed Activities and Pensions 3/16/2017SenatePostponed - Licensed Activities and Pensions 3/16/2017SenateSenate Committee Amendment No. 1 Postponed - Licensed Activities and Pensions 3/17/2017SenateRule 2-10 Committee Deadline Established As April 7, 2017 3/29/2017SenateSenate Committee Amendment No. 1 Adopted 3/29/2017SenateDo Pass as Amended Licensed Activities and Pensions; 012-000-000 3/29/2017SenatePlaced on Calendar Order of 2nd Reading March 30, 2017 4/5/2017SenateAdded as Chief Co-Sponsor Sen. Melinda Bush 4/26/2017SenateAdded as Chief Co-Sponsor Sen. Kyle McCarter 4/26/2017SenateAdded as Chief Co-Sponsor Sen. Chris Nybo 4/26/2017SenateSponsor Removed Sen. Chris Nybo 4/26/2017SenateChief Sponsor Changed to Sen. Chris Nybo 4/26/2017SenateSecond Reading 4/26/2017SenatePlaced on Calendar Order of 3rd Reading April 27, 2017 8/4/2017SenatePursuant to Senate Rule 3-9(b) / Referred to Assignments 11/15/2018SenateChief Sponsor Changed to Sen. William E. Brady 1/9/2019SenateSession Sine Die